Home > Qtrly Results > GLAND PHARMA

GLAND PHARMA
Quarterly Results Analysis [Jun2026]

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹1,800 Cr ₹1,743 Cr ₹1,695 Cr ₹1,487 Cr ₹1,506 Cr ₹1,425 Cr ₹1,384 Cr ₹1,406 Cr
Expenses ₹1,311 Cr ₹1,230 Cr ₹1,260 Cr ₹1,173 Cr ₹1,138 Cr ₹1,077 Cr ₹1,024 Cr ₹1,109 Cr
Operating Income ₹489 Cr ₹513 Cr ₹435 Cr ₹314 Cr ₹368 Cr ₹348 Cr ₹360 Cr ₹297 Cr
Other Income ₹61 Cr ₹111 Cr ₹63 Cr ₹84 Cr ₹58 Cr ₹44 Cr ₹58 Cr ₹60 Cr
Interest ₹4 Cr ₹10 Cr ₹4 Cr ₹8 Cr ₹11 Cr ₹7 Cr ₹23 Cr ₹6 Cr
Depreciation ₹111 Cr ₹109 Cr ₹108 Cr ₹106 Cr ₹101 Cr ₹96 Cr ₹96 Cr ₹94 Cr
Profit Before Tax ₹435 Cr ₹506 Cr ₹362 Cr ₹284 Cr ₹313 Cr ₹288 Cr ₹299 Cr ₹257 Cr
Profit After Tax ₹317 Cr ₹367 Cr ₹261 Cr ₹184 Cr ₹215 Cr ₹187 Cr ₹205 Cr ₹164 Cr
EPS ₹19.21 ₹22.26 ₹15.87 ₹11.15 ₹13.08 ₹11.32 ₹12.42 ₹9.93
Industry Peers & Returns1W1M1Y
GLAND PHARMA 1.5% 12% 55.4%
SUN PHARMACEUTICAL INDUSTRIES -2.9% -2.3% 21.8%
DIVIS LABORATORIES -1.6% 9.8% 51.8%
TORRENT PHARMACEUTICALS -2.6% -2.3% 37.5%
CIPLA -2.2% -6.1% -12.5%
DR REDDYS LABORATORIES -0.9% -1.8% -9.8%
MANKIND PHARMA -2.9% -4.2% -6.9%
LUPIN -3.1% -11.7% 12.5%
ZYDUS LIFESCIENCES -3.5% 1.3% 14.6%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

3.30 %

Y-o-Y

19.57 %

Quarters Revenues % Change
Jun2026 ₹1,800 Cr
3.30
Mar2026 ₹1,743 Cr
2.80
Dec2025 ₹1,695 Cr
14.02
Sep2025 ₹1,487 Cr
-1.25
Jun2025 ₹1,506 Cr
5.66
Mar2025 ₹1,425 Cr
2.95
Dec2024 ₹1,384 Cr
-1.55
Sep2024 ₹1,406 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-4.61 %

Y-o-Y

33.07 %

Quarters Operating Profit % Change
Jun2026 ₹489 Cr
-4.61
Mar2026 ₹513 Cr
17.97
Dec2025 ₹435 Cr
38.55
Sep2025 ₹314 Cr
-14.65
Jun2025 ₹368 Cr
5.83
Mar2025 ₹348 Cr
-3.46
Dec2024 ₹360 Cr
21.17
Sep2024 ₹297 Cr -
Operating Margins
Q-o-Q

-7.68 %

Y-o-Y

11.26 %

Quarters Operating Margin% % Change
Jun2026 27.18%
-7.68
Mar2026 29.44%
14.78
Dec2025 25.65%
21.51
Sep2025 21.11%
-13.59
Jun2025 24.43%
0.16
Mar2025 24.39%
-6.23
Dec2024 26.01%
23.10
Sep2024 21.13% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-13.56 %

Y-o-Y

47.09 %

Quarters Profit After Tax % Change
Jun2026 ₹317 Cr
-13.56
Mar2026 ₹367 Cr
40.23
Dec2025 ₹261 Cr
42.35
Sep2025 ₹184 Cr
-14.76
Jun2025 ₹215 Cr
15.51
Mar2025 ₹187 Cr
-8.87
Dec2024 ₹205 Cr
25.17
Sep2024 ₹164 Cr -
PAT Margins
Q-o-Q

-16.30 %

Y-o-Y

23.06 %

Quarters PAT Margin(%) % Change
Jun2026 17.61 %
-16.30
Mar2026 21.04 %
36.45
Dec2025 15.42 %
24.86
Sep2025 12.35 %
-13.70
Jun2025 14.31 %
9.32
Mar2025 13.09 %
-11.49
Dec2024 14.79 %
27.17
Sep2024 11.63 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-13.70 %

Y-o-Y

46.87 %

Quarters EPS % Change
Jun2026 ₹19.21
-13.70
Mar2026 ₹22.26
40.26
Dec2025 ₹15.87
42.33
Sep2025 ₹11.15
-14.76
Jun2025 ₹13.08
15.55
Mar2025 ₹11.32
-8.86
Dec2024 ₹12.42
25.08
Sep2024 ₹9.93 -

You may also like the below Video Courses